GlassScriptPhysician profile
Akram Mahmoud
NPI 1982694642
$151,605.96
in general payments reported to CMS, 2019-2025
17 companies · $5,677 in 2025
The $5,677 reported for 2025 was more than what 81% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $30K · 2021: $33K · 2022: $33K · 2023: $9,821 · 2024: $920 · 2025: $5,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $15K · Food and Beverage: $997 · Travel and Lodging: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,083.61 |
| Food and Beverage | $996.89 |
| Travel and Lodging | $337.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acuity Surgical Devices, LLC | $81,346.78 | 2019-2025 | |
| Globus Medical, INC. | $62,875.55 | 2019-2022 | |
| Ulrich Medical USA, INC. | $4,360.02 | 2019-2022 | |
| Medtronic, INC. | $1,314.42 | 2021-2025 | Strata, Mazor X System, O-Arm |
| Stryker Corporation | $562.84 | 2022-2025 | N/A |
| Abbott Laboratories | $337.45 | 2023 | Proclaim |
| Nuvasive, INC. | $206.24 | 2022 | |
| Boston Scientific Corporation | $152.21 | 2019 | |
| Nevro Corp. | $93.05 | 2019 | |
| Genzyme Corporation | $88.64 | 2019 | |
| Medtronic USA, INC. | $67.67 | 2019 | |
| Spinal Elements, INC. | $55.05 | 2020 | |
| Aesculap Implant Systems, LLC | $47.12 | 2020 | |
| Amgen INC. | $32.54 | 2019 | |
| Arbor Pharmaceuticals, INC. | $32.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $19.24 | 2019 | |
| Eisai INC. | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akram Mahmoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.